The Indian patent office denied a drug patent application by U.S. pharmaceutical company Abbott Laboratories for the combination of lopinavir/ritonavir over the weekend, stating that the patenting was “not an invention.” The drug combination is a protease inhibitor used as a second line regimen to treat patients with HIV, and the patent denial opens the […]
HIV
As the federal Ending the HIV epidemic takes form, experts talk details, challenges: “How do we get there from here?” WASHINGTON, DC – Nearly four decades […]
Tuberculosis
Patients treated for multidrug-resistant tuberculosis with an experimental regimen containing a repurposed drug for a year had similar rates of successful outcomes as patients treated with […]
Research & Development
While a World Health Organization-led strategy aims to provide 1.4 billion doses of vaccine against yellow fever to achieve 80% vaccination coverage across countries by 2026 […]
Policy
The following is a guest post By Sharon Weir, Ph.D. of MEASURE Evaluation The Priorities for Local AIDS Control Efforts — PLACE –method aims to improve […]